Avinger to Announce First Quarter 2019 Financial Results on May 8, 2019
REDWOOD CITY, CA / ACCESSWIRE / May 2, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing...
user
International Cannabrands Announces New Appointments to Management Team and Comments on Year End Results
DENVER, CO / ACCESSWIRE / May 2, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
Viveve to Host Conference Call to Discuss First Quarter 2019 Financial and Operating Results on May 9, 2019
ENGLEWOOD, CO / ACCESSWIRE / May 2, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
Preferred Dental Technologies Inc. (”Company”) (CSE: PDTI, US OTC: PDTTF): EAS Custom Dental Abutment System Receives Positive Review from Industry Legend
WINNIPEG, MB / ACCESSWIRE / May 2, 2019 / Preferred Dental Technologies Inc. ("Company") (CSE: PDTI, US OTC: PDTTF): EAS...
Avolynt, Inc. Announces First Marketing Authorization and Commercial Launch of Novel SGLT2 Inhibitor Remogliflozin Etabonate for Type 2 Diabetes
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / May 2, 2019 / Avolynt, Inc., a company focused on the development of...
VistaGen Reports Top Line Results from NIMH’s Exploratory Study of AV-101 Monotherapy for Treatment-Resistant Depression
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 2, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
EyeGate Files IDE with FDA for PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / May 2, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (''EyeGate'' or ''the Company'') announced today...
Trinity Dental Arts to Host Dental Implant Seminar
Lunch & Learn Session Set for May 10, 2019 TRINITY, FL / ACCESSWIRE / May 1, 2019 / Trinity Dental...
EllisLab Launches ExpressionEngine Add-on Marketplace
ExpressionEngine users can now buy add-ons for e-commerce and more on ExpressionEngine.com. SANTA BARBARA, CA / ACCESSWIRE / May 1,...
National Brain Tumor Society Issues Calls to Action During Brain Tumor Awareness Month 2019
Patient advocacy leader again declaring its community's national recognition month as Brain Tumor ACTION Month BOSTON, MA / ACCESSWIRE /...
Callitas Health Announces Late Filing of Annual Financial Disclosure
CINCINNATI, OH / ACCESSWIRE / May 1, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF,...
Easton Announces That it Is Moving its Corporate Office After the Purchase of its Food Processing Company Specializing in Baked Goods and the Launch of its New Website
TORONTO, ON / ACCESSWIRE / April 30, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) executive management is pleased to...
Notice of Annual General Meeting and Explanatory Memorandum
SYDNEY, AUSTRALIA / ACCESSWIRE / April 30, 2019 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK: PARNF), a fully integrated, commercial-stage...
Arcutis, Inc. Announces Board of Directors
Board Comprised of Leading Dermatology Experts and Lifescience Investors WESTLAKE VILLAGE, CA / ACCESSWIRE / April 30, 2019 / Arcutis,...
Adial Pharmaceuticals CEO to Present at the ThinkEquity Conference on May 2nd in New York City
CHARLOTTESVILLE, VA / ACCESSWIRE / April 30, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused...
Canadabis Capital Resumes Trading and Launches Corporate Website
CALGARY, AB / ACCESSWIRE / April 30, 2019 / CanadaBis Capital Inc.("CanadaBis or the Company") is pleased to announce that...
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
FT. MYERS, FL / ACCESSWIRE / April 30, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
Biom’up reports 2018 full-year results and provides a business update
Biom'up reports 2018 full-year results and confirms strong commercial uptake in 1st quarter of 2019 SAINT-PRIEST, FRANCE / ACCESSWIRE /...
LED Medical Diagnostics Inc. Reports 2018 Results
VANCOUVER, BC / ACCESSWIRE / April 29, 2019 / LED Medical Diagnostics Inc. ("LED" or the "Company"), a leading dental...
MorphoSys and I-Mab Biopharma Announce First Patient Dosed in Phase 3 Clinical Study of MOR202/TJ202 in Multiple Myeloma
PLANEGG/MUNICH, GERMANY and SHANGHAI, CHINA / ACCESSWIRE / April 29, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX...